Skip to content

Solesence, Inc. Common Stock SLSN Q4 2024 Annual earnings

Reported March 26, 2025 · After market close

Next report

Aug 6, 2026 (In 3 weeks)

Financials

Q4 2024

Income statement

See full
Revenue$12.6M+56.9%
Gross profit$2.8M+487%
Operating income-+100%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$1.4M-18.2%
Total debt$10.3M-10.1%
Total equity$14.9M+686%
Total assets$50.0M+52.1%

Cash flow

See full
Operating cash flow$2.2M+183%
CapEx$2.6M+1,203%
Free cash flow-$404.0K+85.8%

Valuation & ratios

Profitability

See full
Gross margin30.9%+9.9pp
Operating margin10.2%+6.9pp

Returns & leverage

See full
Debt / equity0.7×-5.3×
Current ratio1.1×+0.1×

Segments

By product

See full
Consumer Products$11.5M
Personal Care Ingredients$861.0K
Advanced Materials$237.0K

By geography

See full
Non Us$335.0K

Versus estimates

Ask the moment Solesence, Inc. Common Stock reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Solesence, Inc. Common Stock report Q4 2024 earnings?
Solesence, Inc. Common Stock (SLSN) reported Q4 2024 earnings on March 26, 2025 after market close.
What were Solesence, Inc. Common Stock's Q4 2024 revenue and EPS?
Solesence, Inc. Common Stock reported revenue of $12.6M and diluted EPS of $-0.01 for Q4 2024.
Where can I find Solesence, Inc. Common Stock's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001999371-25-003471) directly on SEC EDGAR. The filing index links above go to sec.gov.